Form 4: Abeona Therapeutics Executive Sells Shares to Cover Tax Obligations

Brendan M. O'Malley, SVP and General Counsel of Abeona Therapeutics, disposed of 496 shares of common stock to cover tax obligations upon vesting of restricted stock on September 20, 2024.

Summary

• On September 20, 2024, Brendan M. O'Malley, the SVP and General Counsel of Abeona Therapeutics, disposed of 496 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations upon the vesting of restricted stock.
• The shares were sold at a price of $6.02 per share.
• Following the transaction, O'Malley directly owns 279,868 shares of Abeona Therapeutics.
• The transaction was reported on September 24, 2024.

Sentiment

Score: 5

Explanation: This is a routine transaction to cover tax obligations, so it's neutral in sentiment.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting of restricted stock.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but it is a common practice for covering tax obligations.

Key Dates